Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prozac patent strategy

Executive Summary

Lilly does not believe aaiPharma's fluoxetine purification patent "meets FDA's standards for listing in the 'Orange Book'" and therefore decided not to "further pursue" obtaining rights to the technology, the company says. While Lilly will continue to enforce its own Prozac patents it will not engage in "last-minute legal maneuvers" to extend Prozac's exclusivity (1see related story, p. 19). Lilly indicated that public relations tactics played a role in its decision. aaiPharma's patent (6,258,853) on a pure crystalline form of fluoxetine Form A was issued by the Patent & Trademark Office July 10
Advertisement

Related Content

AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others
AstraZeneca Mulls AaiPharma Omeprazole Patent; Will Not List Two Others
AaiPharma Fast-Acting Diclofenac NDA Filing Planned For 2002
Barr Fluoxetine Goal: 80% Generic Penetration In First Six Months
AaiPharma Fast-Acting Diclofenac NDA Filing Planned For 2002
Barr Fluoxetine Goal: 80% Generic Penetration In First Six Months
Lilly Prozac Rehearing Petition Could Receive Ruling By End Of July, Barr Says
Lilly Prozac Rehearing Petition Could Receive Ruling By End Of July, Barr Says
Advertisement
UsernamePublicRestriction

Register

PS038190

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel